β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes:: A new analysis

被引:403
作者
Ferrannini, E
Gastaldelli, A
Miyazaki, Y
Matsuda, M
Mari, A
DeFronzo, RA
机构
[1] Univ Pisa, Sch Med, Dept Internal Med, I-56100 Pisa, Italy
[2] Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA
[3] Univ Pisa, Sch Med, Inst Clin Physiol, Consiglio Nazl Ric, I-56100 Pisa, Italy
[4] CNR, Inst Biomed Engn, I-35127 Padua, Italy
关键词
D O I
10.1210/jc.2004-1133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nature of the progressive beta-cell failure occurring as normal glucose tolerant (NGT) individuals progress to type 2 diabetes (T2DM) is incompletely understood. We measured insulin sensitivity ( by a euglycemic insulin clamp) and insulin secretion rate ( by deconvolution of plasma C-peptide levels during an oral glucose tolerance test) in 188 subjects [ 19 lean NGT ( body mass index [BMI] < 25 kg/m(2)), 42 obese NGT, 22 BMI-matched impaired glucose tolerance [IGT], and 105 BMI-matched T2DM]. Main determinants of beta-cell function on the oral glucose tolerance test were derived from a mathematical model featuring the following: 1) glucose concentration-insulin secretion dose response ( glucose sensitivity), 2) a secretion component proportional to the derivative of plasma glucose concentration ( rate sensitivity); and 3) a potentiation factor. When NGT and T2DM were subgrouped by 2-h plasma glucose concentrations, insulin secretion rate revealed an inverted U-shaped pattern, rising through NGT up to IGT and falling off thereafter. In contrast, beta-cell glucose sensitivity dropped in a monophasic, curvilinear fashion throughout the range of 2-h plasma glucose. Within the NGT range (2-h glucose of 4.1 - 7.7 mmol/liter), beta-cell glucose sensitivity declined by 50 - 70% ( P < 0.02). Insulin sensitivity decreased sharply in the transition from lean to obese NGT and then declined further in IGT and mild T2DM to level off in the higher three quartiles of diabetic hyperglycemia. In T2DM, defective beta-cell potentiation and rate sensitivity also emerged ( P < 0.05). In the whole data set, insulin sensitivity and the dynamic parameters of beta-cell function explained 89% of the variability of 2-h plasma glucose levels. The following conclusions were reached: 1) beta-cell glucose sensitivity falls already within the NGT range in association with rising 2-h plasma glucose concentrations, although absolute insulin secretion rates increase; and 2) throughout the glucose tolerance range, dynamic parameters of beta-cell function ( glucose sensitivity, rate sensitivity, and potentiation) and insulin sensitivity are independent determinants of 2-h plasma glucose levels.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 47 条
  • [21] Signals and pools underlying biphasic insulin secretion
    Henquin, JC
    Ishiyama, N
    Nenquin, M
    Ravier, MA
    Jonas, JC
    [J]. DIABETES, 2002, 51 : S60 - S67
  • [22] QUANTIFICATION OF THE RELATIONSHIP BETWEEN INSULIN SENSITIVITY AND BETA-CELL FUNCTION IN HUMAN-SUBJECTS - EVIDENCE FOR A HYPERBOLIC FUNCTION
    KAHN, SE
    PRIGEON, RL
    MCCULLOCH, DK
    BOYKO, EJ
    BERGMAN, RN
    SCHWARTZ, MW
    NEIFING, JL
    WARD, WK
    BEARD, JC
    PALMER, JP
    PORTE, D
    [J]. DIABETES, 1993, 42 (11) : 1663 - 1672
  • [23] MINIMAL CHRONIC HYPERGLYCEMIA IS A CRITICAL DETERMINANT OF IMPAIRED INSULIN-SECRETION AFTER AN INCOMPLETE PANCREATECTOMY
    LEAHY, JL
    BONNERWEIR, S
    WEIR, GC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (05) : 1407 - 1414
  • [24] IMPAIRED GLUCOSE-TOLERANCE AS A DISORDER OF INSULIN ACTION - LONGITUDINAL AND CROSS-SECTIONAL STUDIES IN PIMA-INDIANS
    LILLIOJA, S
    MOTT, DM
    HOWARD, BV
    BENNETT, PH
    YKIJARVINEN, H
    FREYMOND, D
    NYOMBA, BL
    ZURLO, F
    SWINBURN, B
    BOGARDUS, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (19) : 1217 - 1225
  • [25] Assessing insulin secretion by modeling in multiple-meal tests - Role of potentiation
    Mari, A
    Tura, A
    Gastaldelli, A
    Ferrannini, E
    [J]. DIABETES, 2002, 51 : S221 - S226
  • [26] Meal and oral glucose tests for assessment of β-cell function:: modeling analysis in normal subjects
    Mari, A
    Schmitz, O
    Gastaldelli, A
    Oestergaard, T
    Nyholm, B
    Ferrannini, E
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (06): : E1159 - E1166
  • [27] ROLE OF GLUCOSE AND INSULIN RESISTANCE IN DEVELOPMENT OF TYPE-2 DIABETES-MELLITUS - RESULTS OF A 25-YEAR FOLLOW-UP-STUDY
    MARTIN, BC
    WARRAM, JH
    KROLEWSKI, AS
    BERGMAN, RN
    SOELDNER, JS
    KAHN, CR
    [J]. LANCET, 1992, 340 (8825) : 925 - 929
  • [28] Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
    McGarry, JD
    [J]. DIABETES, 2002, 51 (01) : 7 - 18
  • [29] NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    NAUCK, MA
    KLEINE, N
    ORSKOV, C
    HOLST, JJ
    WILLMS, B
    CREUTZFELDT, W
    [J]. DIABETOLOGIA, 1993, 36 (08) : 741 - 744
  • [30] PRESERVED INCRETIN ACTIVITY OF GLUCAGON-LIKE PEPTIDE-1 [7-36 AMIDE] BUT NOT OF SYNTHETIC HUMAN GASTRIC-INHIBITORY POLYPEPTIDE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    NAUCK, MA
    HEIMESAAT, MM
    ORSKOV, C
    HOLST, JJ
    EBERT, R
    CREUTZFELDT, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) : 301 - 307